MC-VC-PAB-NH2 TFA - CAS 1616727-21-9

MC-VC-PAB-NH2 TFA - CAS 1616727-21-9 Catalog number: BADC-01845

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

MC-VC-PAB-NH2 TFA is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Category
ADCs Linker
Product Name
MC-VC-PAB-NH2 TFA
CAS
1616727-21-9
Catalog Number
BADC-01845
Molecular Formula
C33H47F3N8O10
Molecular Weight
772.77

Ordering Information

Catalog Number Size Price Quantity
BADC-01845 -- $-- Inquiry
Description
MC-VC-PAB-NH2 TFA is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Synonyms
L-Ornithinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[(2-aminoethyl)amino]carbonyl]oxy]methyl]phenyl]-, 2,2,2-trifluoroacetate (1:1)
IUPAC Name
[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]methyl N-(2-aminoethyl)carbamate;2,2,2-trifluoroacetic acid
Canonical SMILES
CC(C)C(C(=O)NC(CCCNC(=O)N)C(=O)NC1=CC=C(C=C1)COC(=O)NCCN)NC(=O)CCCCCN2C(=O)C=CC2=O.C(=O)(C(F)(F)F)O
InChI
InChI=1S/C31H46N8O8.C2HF3O2/c1-20(2)27(38-24(40)8-4-3-5-18-39-25(41)13-14-26(39)42)29(44)37-23(7-6-16-34-30(33)45)28(43)36-22-11-9-21(10-12-22)19-47-31(46)35-17-15-32;3-2(4,5)1(6)7/h9-14,20,23,27H,3-8,15-19,32H2,1-2H3,(H,35,46)(H,36,43)(H,37,44)(H,38,40)(H3,33,34,45);(H,6,7)/t23-,27-;/m0./s1
InChIKey
VRAGHKSLZZJHCO-QAVRJCAVSA-N

MC-VC-PAB-NH2 TFA is a versatile chemical linker utilized in the intricate realm of antibody-drug conjugates (ADCs) for precision-targeted cancer therapy. Here are four key applications of MC-VC-PAB-NH2 TFA:

Antibody-Drug Conjugate Development: Serving as a pivotal cleavable linker in ADC synthesis, MC-VC-PAB-NH2 TFA facilitates the delivery of cytotoxic agents exclusively to malignant cells. This strategic linker ensures the inertness of the drug until it reaches its intended destination, effectively minimizing systemic toxicity. Such targeted drug release not only amplifies the efficacy of cancer treatments but also permits the administration of higher dosages with enhanced safety margins.

Cancer Research: Delving into the intricacies of pharmacokinetics and pharmacodynamics, researchers harness MC-VC-PAB-NH2 TFA to dissect the behavior of ADCs. By scrutinizing the impact of the linker on drug kinetics and stability, scientists glean valuable insights for optimizing ADC structure and functionality. These meticulous investigations contribute to the refinement of cancer therapies, paving the way for more potent treatments with attenuated adverse effects.

Bioconjugation Techniques: At the forefront of bioconjugation methodologies, MC-VC-PAB-NH2 TFA assumes a crucial role in tethering biologically active substances to carrier systems. This capability is particularly invaluable in crafting compounds for diagnostic and imaging applications, enabling precise delivery of probes and contrast agents. The seamless bioconjugation not only heightens the specificity and sensitivity of diagnostic assays but also propels advancements in targeted therapeutic interventions.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Historical Records: MC-VC-PAB-NH2 TFA
Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Resources & Supports
Inquiry Basket